162 related articles for article (PubMed ID: 30585996)
1. Performance of Anti-Topoisomerase I Antibody Testing by Multiple-Bead, Enzyme-Linked Immunosorbent Assay and Immunodiffusion in a University Setting.
Homer KL; Warren J; Karayev D; Khanna PP; Young A; Nagaraja V; Metzger AL; Khanna D
J Clin Rheumatol; 2020 Apr; 26(3):115-118. PubMed ID: 30585996
[TBL] [Abstract][Full Text] [Related]
2. Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides.
Kuwana M; Medsger TA; Wright TM
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):266-78. PubMed ID: 7554448
[TBL] [Abstract][Full Text] [Related]
3. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.
Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R
Front Immunol; 2021; 12():786039. PubMed ID: 34956217
[TBL] [Abstract][Full Text] [Related]
4. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
5. Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation.
Henes J; Glaeser L; Kötter I; Vogel W; Kanz L; Klein R
Rheumatology (Oxford); 2017 Mar; 56(3):451-456. PubMed ID: 27940597
[TBL] [Abstract][Full Text] [Related]
6. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
7. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
8. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
Hénault J; Robitaille G; Senécal JL; Raymond Y
Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
[TBL] [Abstract][Full Text] [Related]
9. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).
Shoenfeld Y; Grunebaum E; Laufer M; Zurgil N; Bakimer R; Lunderschmidt A; Valentini G; Tirri G; Blank M
Isr J Med Sci; 1996 Jul; 32(7):537-42. PubMed ID: 8756980
[TBL] [Abstract][Full Text] [Related]
10. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
[TBL] [Abstract][Full Text] [Related]
11. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.
Radić M; Martinović Kaliterna D; Ljutić D
Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of anti-DNA topoisomerase I autoantibody response after lung cancer in patients with systemic sclerosis. A report of two cases.
Kuwana M; Fujii T; Mimori T; Kaburaki J
Arthritis Rheum; 1996 Apr; 39(4):686-91. PubMed ID: 8630122
[TBL] [Abstract][Full Text] [Related]
13. IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis.
Martínez-Cordero E; Trejo AP; León DE
J Clin Lab Anal; 2009; 23(6):408-16. PubMed ID: 19927342
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
Kuwana M; Okano Y; Pandey JP; Silver RM; Fertig N; Medsger TA
Arthritis Rheum; 2005 Aug; 52(8):2425-32. PubMed ID: 16052583
[TBL] [Abstract][Full Text] [Related]
15. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
Kuwana M; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
[TBL] [Abstract][Full Text] [Related]
17. Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome.
Bankamp L; Preuß B; Pecher AC; Vogel W; Henes J; Klein R
Rheumatology (Oxford); 2023 Jun; 62(6):2168-2177. PubMed ID: 36222553
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
Miyake M; Matsushita T; Takehara K; Hamaguchi Y
Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis.
Sato S; Hamaguchi Y; Hasegawa M; Takehara K
Rheumatology (Oxford); 2001 Oct; 40(10):1135-40. PubMed ID: 11600743
[TBL] [Abstract][Full Text] [Related]
20. Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis.
Boonstra M; Bakker JA; Grummels A; Ninaber MK; Ajmone Marsan N; Wortel CM; Huizinga TWJ; Jordan S; Hoffman-Vold AM; Distler O; Toes REM; Scherer HU; de Vries-Bouwstra JK
Arthritis Rheumatol; 2020 Nov; 72(11):1897-1904. PubMed ID: 32840062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
